PolyPeptide Group AG reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 280.98 million compared to EUR 282.13 million a year ago. Revenue was EUR 283.46 million compared to EUR 286.22 million a year ago.

Net income was EUR 7.77 million compared to EUR 47.26 million a year ago. Basic earnings per share from continuing operations was EUR 0.24 compared to EUR 1.47 a year ago. Diluted earnings per share from continuing operations was EUR 0.24 compared to EUR 1.47 a year ago.